 Wall Street brokerages expect that Eidos Therapeutics Inc NASDAQ:EIDX will announce earnings per share of 0.54 for the current quarter, Zacks reports. Zero analysts have issued estimates for Eidos Therapeutics earnings, with the highest EPS estimate coming in at 0.47 and the lowest estimate coming in at 0.58. Eidos Therapeutics posted earnings per share of ... 